Skip to main content

Avid Bioservices, Inc.

CDMODelisted Feb 5, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0000704562

Avid Bioservices, Inc. was delisted on Feb 5, 2025; its insiders filed their last Form 4 on Feb 7, 2025; 196 institutions reported holding it in 13F filings for Q4 2024, worth $840.8M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Avid Bioservices, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Avid Bioservices, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Avid Bioservices, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Carleone JosephDirector0Feb 7, 20250
Sargen GregoryDirector0Feb 7, 20250
Hart Daniel RChief Financial Officer0Feb 7, 20250
Ziebell Mark RV. P., General Counsel0Feb 7, 20250
Mackey Catherine JDirector0Feb 7, 20250
Hancock Richard BDirector0Feb 7, 20250
Green Nicholas StewartPresident & CEO0Feb 7, 20250
Thoma JeanneDirector0Feb 7, 20250
Alegria Esther M.Director0Feb 7, 20250
Kwietniak Matthew R.Chief Commercial Officer0Feb 7, 20250
Richieri Richard A.Chief Operations Officer0IndirectFeb 7, 20250

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 15, 2024 (view filing)Jul 123 daysKwietniak Matthew R.Chief Commercial OfficerSSaleCommon Stock, $0.001 par value−119$8.05−$957.95−0.5%22.8K after
Jul 16, 2024 (view filing)Jul 151 dayKwietniak Matthew R.Chief Commercial OfficerSSaleCommon Stock, $0.001 par value−307$8.36−$2.57K−1.3%23.4K after
Jul 16, 2024 (view filing)Jul 151 dayRichieri Richard A.Chief Operations OfficerSSaleCommon Stock, $0.001 par value−530$8.36−$4.43K−1.5%34.2K after
Oct 11, 2024 (view filing)Oct 101 dayGreen Nicholas StewartPresident & CEOSSaleCommon Stock, $0.001 par value−17.2K$10.05−$172.6K−7.0%226.7K after
Oct 11, 2024 (view filing)Oct 101 dayKwietniak Matthew R.Chief Commercial OfficerSSaleCommon Stock, $0.001 par value−982$10.05−$9.87K−3.8%25.2K after
Oct 11, 2024 (view filing)Oct 101 dayRichieri Richard A.Chief Operations OfficerSSaleCommon Stock, $0.001 par value−2.03K$10.05−$20.4K−5.1%37.7K after
Oct 11, 2024 (view filing)Oct 101 dayRichieri Richard A.Chief Operations OfficerSSaleCommon Stock, $0.001 par value−201$10.05−$2.02K−2.7%7.22K after
Oct 15, 2024 (view filing)Oct 141 dayKwietniak Matthew R.Chief Commercial OfficerSSaleCommon Stock, $0.001 par value−119$10.15−$1.21K−0.5%25.4K after
Dec 26, 2024 (view filing)Dec 20-246 daysGreen Nicholas StewartPresident & CEOSSaleCommon Stock, $0.001 par value−226.7K$12.29−$2.79M−100.0%0 after3 lots
Dec 27, 2024 (view filing)Dec 261 dayGreen Nicholas StewartPresident & CEOSSaleCommon Stock, $0.001 par value−145.9K$12.22−$1.78M−48.1%157.6K after2 lots
Dec 27, 2024 (view filing)Dec 261 dayHart Daniel RChief Financial OfficerSSaleCommon Stock, $0.001 par value−22.8K$12.22−$278.8K−17.1%111.0K after2 lots
Dec 27, 2024 (view filing)Dec 261 dayKwietniak Matthew R.Chief Commercial OfficerSSaleCommon Stock, $0.001 par value−13.4K$12.22−$163.6K−20.9%50.8K after2 lots
Dec 27, 2024 (view filing)Dec 261 dayRichieri Richard A.Chief Operations OfficerSSaleCommon Stock, $0.001 par value−3.84K$12.22−$47.0K−7.9%44.6K after
Jan 13, 2025 (view filing)Jan 103 daysRichieri Richard A.Chief Operations OfficerSSaleCommon Stock, $0.001 par value−2.28K$12.37−$28.2K−4.4%49.5K after
Jan 13, 2025 (view filing)Jan 103 daysRichieri Richard A.Chief Operations OfficerSSaleCommon Stock, $0.001 par value−200$12.37−$2.47K−2.2%8.79K after